bexarotene has been researched along with Amyloidosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brunden, KR; Casali, BT; Cirrito, JR; Cramer, PE; Goebel, WD; James, MJ; Karlo, JC; Landreth, GE; Lee, CY; Restivo, JL; Wesson, DW; Wilson, DA; Zinn, AE | 1 |
1 other study(ies) available for bexarotene and Amyloidosis
Article | Year |
---|---|
ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Animals; Apolipoproteins E; Astrocytes; Behavior, Animal; Bexarotene; Brain; Disease Models, Animal; Extracellular Fluid; Liver X Receptors; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Molecular Targeted Therapy; Odorants; Olfactory Pathways; Orphan Nuclear Receptors; Phagocytosis; Plaque, Amyloid; PPAR gamma; Retinoid X Receptors; Tetrahydronaphthalenes | 2012 |